Dihydroergotamine methanesulphonate
Sold as Migranal nasal, Dihydergot
No structure available
This product's active ingredient could not be matched to a single known compound.
Background
Registration
- Applicants
- 2
- Registrations
- 3
Applicants and registrations
| Applicant | Brands | Dosages | Registrations | Schedule | Leaflets |
|---|---|---|---|---|---|
| Pharmaco Distribution (Pty) LtdCancelled | Migranal nasal, Dihydergot | spray, ampoule | 330126, H0609 | Not determined | None |
| Sandoz South Africa (Pty) Ltd | Dihydergot | tablet | H0584 | Not determined | None |
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Migranal nasal spray EACH 1,0 ml SOLUTION CONTAINS DIHYDROERGOTAMINE METHANESULPHONATE 4,0 mg | Spray | 33012633/7.3/0126 | Cancelled | Not determined | None |
| Dihydergot tablet EACH TABLET CONTAINS DIHYDROERGOTAMINE METHANESULPHONATE A 1,0 mg | Tablet | H0584 | Old Medicine | Not determined | None |
| Dihydergot ampoule EACH ML CONTAINS DIHYDROERGOTAMINE METHANESULPHONATE A 1,0 mg | Ampoule | H0609 | Cancelled | Not determined | None |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
SAHPRA documents
SAHPRA has not published a professional information or patient information leaflet for this product.